Top Story

Autologous antigen-loaded vaccine safe, feasible for neuroblastoma

November 9, 2019
In the Journals

Plasma cell-free DNA may predict glioblastoma progression

November 4, 2019
Plasma cell-free DNA appeared to be an effective biomarker for tumor burden and a viable prognostic tool for disease progression among newly-diagnosed patients with…

Vincristine shortage underscores vulnerability of ‘fragile market’ for crucial treatments

October 23, 2019
A shortage of the chemotherapy drug vincristine, which is essential to the treatment of most pediatric cancers, has left the oncology community struggling to find…

ID1 inhibition may improve efficacy of glioblastoma treatment

October 18, 2019
Investigators from St. Michael’s Hospital and The Hospital for Sick Children in Toronto have determined that the transcriptional regulatory protein ID1 appears to…
More Headlines »

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Meeting News

VIDEO: ASCO features pivotal data readouts from AstraZeneca portfolio

June 17, 2018
More »

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »